IMMUNOPLUS
Live / Registered — Registered (as of 11 Jun 2024)
What this means for you
Registered since 11 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79384162
- Registration number
- 7410943
- Mark type
- Word mark
- Filed
- 13 Sept 2023
- Published for opposition
- 26 Mar 2024
- Registered
- 11 Jun 2024
Goods and services
- Class 042 — Scientific and technological services: Scientific, technological and medical research services, namely, the service of providing gene synthesis, oligo synthesis, cloning, protein expression, peptide synthesis and antibody production, genome modification, cell line establishment, animal model establishment, in vivo and in vitro assays; product quality testing; biochemical research and analysis; gene therapy research; dna screening for scientific research purposes; biological cloning services; biological research and analysis; medical and scientific research, namely, conducting clinical trials for others; medical research; scientific research in the field of genetics; biological research; development of gene-based medicines; research and development services in the field of antibodies
Owner
Prosecution history
- 17 May 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 29 Apr 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Apr 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 11 Jul 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 11 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 26 Mar 2024 — PUBLISHED FOR OPPOSITION
- 06 Mar 2024 — NOTICE OF PUBLICATION
- 20 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Feb 2024 — ASSIGNED TO EXAMINER
- 22 Dec 2023 — APPLICATION FILING RECEIPT MAILED
- 18 Dec 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Dec 2023 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 30 Nov 2023 — SN ASSIGNED FOR SECT 66A APPL FROM IB